Benzinga
Benzinga
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
Benzinga
venerdì, ottobre 23
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
Castle Biosciences Inc
CSTL
NASDAQ
Watchlist
Get Report
Trade with Public
Get Report
Trade with Public
$33.19
-1.18
-3.43%
Ult. Agg.: Oct 22, 4:00 PM
$33.19
-1.18
-3.43%
Get Report
Panoramica
Notizie
Previsioni utili
Eventi
Obiettivi di prezzo
Dati finanziari
Sentiment
Azionariato
Confronta
Opzioni
Rapporto azionario
Privacy Manager
Utili:
I risultati di Q3 2026 tra 14 giorni da adesso in gio nov 5th, dopo la chiusura del mercato
Castle Biosciences Analyst Price Targets - Benzinga
Castle Biosciences Analyst Price Targets
Wall Street analyst price targets and consensus rating for Castle Biosciences (CSTL).
Analyst Ratings News
PRO
BTIG Maintains Buy on Castle Biosciences, Raises Price Target to $44
BTIG analyst Mark Massaro maintains Castle Biosciences (NASDAQ:CSTL) with a Buy and raises the price target from $40 to $44.
Benzinga Newsdesk
This Keurig Dr Pepper Analyst Turns Bullish; Here Are Top 4 Upgrades For Thursday
Top Wall Street analysts changed outlook on top names. See all changes incl. upgrades, downgrades & initiations on analyst ratings page.
Avi Kapoor
This PVH Analyst Turns Bearish; Here Are Top 3 Downgrades For Thursday
Wall Street analysts change outlook on top names, with downgrades and initiations. See analyst ratings page for complete view.
Avi Kapoor
This Tonix Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
Analysts changed outlook on top names, including Intel and Arrow Financial. See ratings page. TNXP stock may be worth considering, analysts say.
Avi Kapoor
PRO
Roth Capital Initiates Coverage On Castle Biosciences with Buy Rating, Announces Price Target of $40
Roth Capital analyst Max Masucci initiates coverage on Castle Biosciences (NASDAQ:CSTL) with a Buy rating and announces Price Target of $40.
Benzinga Newsdesk
PRO
BTIG Maintains Buy on Castle Biosciences, Lowers Price Target to $40
BTIG analyst Mark Massaro maintains Castle Biosciences (NASDAQ:CSTL) with a Buy and lowers the price target from $50 to $40.
Benzinga Newsdesk
Crea una watchlist
GRATIS: Segui le azioni e criptovalute con le migliori notifiche di internet
Clicca per iniziare
People Also Watch
CVS Health Corp
NYSE:CVS
$94.5
0.02%
The Cigna Group
NYSE:CI
$316
0.04%
Labcorp Holdings Inc
NYSE:LH
$326.84
-0.94%
Quest Diagnostics Inc
NYSE:DGX
$238.42
-2%
Guardant Health Inc
NASDAQ:GH
$162.94
-%
DaVita Inc
NYSE:DVA
$187.94
0.99%
BrightSpring Health Services Inc
NASDAQ:BTSG
$60.86
-%
Fresenius Medical Care AG
NYSE:FMS
$21.59
-2.88%
Hinge Health Inc
NYSE:HNGE
$109.93
-%
Chemed Corp
NYSE:CHE
$520.15
-%
Mostra tutte le 10 aziende correlate
